| Availability: | |
|---|---|
INCI Name | Acetyl Hexapeptide‑8, Palmitoyl Pentapeptide‑4 |
CAS Number | 616204‑22‑9, 214047‑00‑4 |
Appearance | Colorless to yellowish, transparent solution |
PH | 4.0–6.0 |
Recommended Dosage | 1.8%–10% |
Key Benefits
· Dual‑action anti‑wrinkle – Relaxes expression lines via Acetyl Hexapeptide‑8 while Palmitoyl Pentapeptide‑4 boosts collagen production to fill static wrinkles.
· Collagen synthesis & photo‑repair – Stimulates new collagen formation and helps reverse UV‑induced damage.
· Barrier reinforcement – Strengthens the skin’s natural defensive layer, improving resilience and hydration retention.
Clinical Efficacy
Human clinical studies have validated the performance of WKPep®Facepep 03:
· Elasticity improvement – In a 30‑subject split‑face trial, a 3% serum applied twice daily significantly increased skin elasticity parameters (R2, R5, and R7) measured with an MPA580 Cutometer, compared to placebo.
· Wrinkle reduction – At 5% concentration, the serum reduced crow’s‑feet wrinkle depth, area, and length after 42 days of twice‑daily application, as quantified by PRIMOS‑CR 3D fringe projection.
These results confirm that WKPep®Facepep 03 delivers clinically meaningful anti‑aging benefits at low inclusion rates, offering formulators a versatile and efficacious active for serums, creams, and eye treatments. Its proven safety profile and hypoallergenic nature make it ideal for sensitive skin applications.